Retatrutide is a triple agonist drug designed to activate three hormone receptors: GLP-1 , GIP , and Glucagon (GCGR)
Globally, around 152 million men (as per 1995 data) experience Erectile Dysfunction (ED), a condition affecting both physical and emotional well-being
Metastasis, the spread of cancer cells from the primary tumor to distant sites, is a hallmark of cancer and a major cause of cancer-related mortality [117]
New England Journal of Medicine (NEJM) Semaglutide and tirzepatide clinical research
Cai Y, Chen X, Yi B, Li J, Wen Z (2022) Pathophysiology roles for adenosine 2A receptor in obesity and related diseases
The Histogenesis and Biologic Behaviour of Primary Human Malignant Melanoma of the Skin